comparemela.com

Latest Breaking News On - Blueprint medicines corp - Page 4 : comparemela.com

Blueprint Medicines Corp (BPMC) Reports Q3 2023 Earnings

Revenue Growth and Operational Efficiency Highlighted in Latest Financial Results

Kate havilandCompany outlookBlueprint medicines corpCompany cash positionMedicines corpCash equivalentsPerational efficiencyProduct revenuesNet loss

Blueprint Medicines: Q3 Earnings Snapshot

CAMBRIDGE, Mass. (AP) CAMBRIDGE, Mass. (AP) Blueprint Medicines Corp. (BPMC) on Thursday reported a loss of $133.7 million in its third quarter.

United kingdomUnited statesBlueprint medicines corpZacks investment researchBlueprint medicinesWall streetAutomated insightsZacks investmentEarns blueprint medicines

BPMC Stock Price | Blueprint Medicines Corp Stock Quote (U S : Nasdaq)

BPMC | Complete Blueprint Medicines Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Etby jaimy leeBlueprint medicines corpBlueprint medicinesPmc analyst estimatesPmc earnings estimatesPmc share estimatesPmc analyst recommendationsPmc ratingsLueprint medicines corp analyst estimatesLueprint medicines corp earnings estimatesLueprint medicines corp analyst recommendationsLueprint medicines corp analyst ratings

Insider Sell: Fouad Namouni Sells 3,769 Shares of Blueprint Medicines Corp

On October 4, 2023, Fouad Namouni, President of R & D at Blueprint Medicines Corp (NASDAQ:BPMC), sold 3,769 shares of the company.

Blueprint medicines corpMedicines corpGurufocus valueIopharmaceutical companyFouad namouni

Director Jeffrey Albers Sells 25,000 Shares of Blueprint Medicines Corp

On September 28, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 25,000 shares of the company's stock.

Jeffrey albersBlueprint medicines corpGurufocus valueDirector jeffrey albersBlueprint medicinesJeffrey albersNsider transactionsBlueprint medicines corp

vimarsana © 2020. All Rights Reserved.